Breaking News, Collaborations & Alliances, Trials & Filings

Trials & Filings in Brief: Jan. 15, 2014

AbbVie, Antares, Elite, Galectin, La Jolla

Phase I
Galectin drug in early test against melanoma . . . read more

Phase II
La Jolla launches extension study . . . read more

Phase III
AbbVie begins triple-negative breast cancer trial . . . read more

505(b)2
Dosing begins for Elite bioequivalence study . . . read more

Launches
Antares releases subcutaneous MTX . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters